A naturally occurring variant in human TLR9, P99L, is associated with loss of CpG oligonucleotide responsiveness.

A naturally occurring variant in human TLR9, P99L, is associated with loss of CpG oligonucleotide responsiveness.

The innate immune system employs Toll-like receptors (TLRs) for the detection of invading microorganisms based on distinct molecular patterns. For example, TLR9 is activated by microbial DNA and also by short therapeutic CpG-containing oligonucleotides (CpG-ODN). TLR9 activation leads to the product...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Kubarenko, A, Ranjan, S, Rautanen, A, Mills, T, Wong, S, Vannberg, F, Neumaier, M, Bekeredjian-Ding, I, Hill, A, Ahmad-Nejad, P, Weber, A
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2010

Míreanna comhchosúla

Competition by inhibitory oligonucleotides prevents binding of CpG to C-terminal TLR9
de réir: Avalos, Ana M., et al.
Foilsithe / Cruthaithe: (2014)

MyD88 adaptor-like D96N is a naturally occurring loss-of-function variant of TIRAP.
de réir: George, J, et al.
Foilsithe / Cruthaithe: (2010)

Immunotherapeutic Potential of CpG Oligonucleotides in Chickens
de réir: Arshud Dar, et al.
Foilsithe / Cruthaithe: (2009-04-01)

CpG Oligonucleotides as Cancer Vaccine Adjuvants
de réir: Hidekazu Shirota, et al.
Foilsithe / Cruthaithe: (2015-05-01)

Introduction of sugar-modified nucleotides into CpG-containing antisense oligonucleotides inhibits TLR9 activation
de réir: Tokuyuki Yoshida, et al.
Foilsithe / Cruthaithe: (2024-05-01)

The Study of the Therapeutic Effects of CpG Oligonucleotides in Murine Model of Allergic Asthma
de réir: T. Mousavi, et al.
Foilsithe / Cruthaithe: (2007-07-01)

The Study of the Therapeutic Effects of CpG Oligonucleotides in Murine Model of Allergic Asthma
de réir: T Mousavi, et al.
Foilsithe / Cruthaithe: (2007-06-01)

Phosphate-modified CpG oligonucleotides induce in vitro maturation of human myeloid dendritic cells
de réir: A. A. Ostanin, et al.
Foilsithe / Cruthaithe: (2020-10-01)

The Study of the Therapeutic Effects of CpG Oligonucleotides in Murine Model of Allergic Asthma
de réir: T Mousavi
Foilsithe / Cruthaithe: (2012-05-01)

Effect of Calcium Carbonate Encapsulation on the Activity of Orally Administered CpG Oligonucleotides
de réir: Neslihan Kayraklioglu, et al.
Foilsithe / Cruthaithe: (2017-09-01)

In Vivo TLR9 Inhibition Attenuates CpG-Induced Myocardial Dysfunction
de réir: O. Boehm, et al.
Foilsithe / Cruthaithe: (2013-01-01)

The counter regulatory response induced by CpG oligonucleotides prevents bleomycin induced pneumopathy
de réir: Kinjo Takeshi, et al.
Foilsithe / Cruthaithe: (2012-06-01)

Synthetic Hexanucleotides as a Tool to Overcome Excessive Neutrophil Activation Caused by CpG-Containing Oligonucleotides
de réir: Ekaterina A. Golenkina, et al.
Foilsithe / Cruthaithe: (2021-04-01)

Two human MYD88 variants, S34Y and R98C, interfere with MyD88-IRAK4-myddosome assembly.
de réir: George, J, et al.
Foilsithe / Cruthaithe: (2011)

CpG oligonucleotide activates Toll-like receptor 9 and causes lung inflammation in vivo
de réir: Hoeft Andreas, et al.
Foilsithe / Cruthaithe: (2007-10-01)

CpG-containing oligonucleotides are efficient adjuvants for induction of protective antiviral immune responses with T-cell peptide vaccines.
de réir: Oxenius, A, et al.
Foilsithe / Cruthaithe: (1999)

Multiple Immunosuppressive Effects of CpG-c41 on Intracellular TLR-Mediated Inflammation
de réir: Wancheng Liu, et al.
Foilsithe / Cruthaithe: (2017-01-01)

Prophylactic application of CpG oligonucleotides augments the early host response and confers protection in acute melioidosis.
de réir: Barbara M Judy, et al.
Foilsithe / Cruthaithe: (2012-01-01)

CpG Oligonucleotides Protect Mice From Alphavirus Encephalitis: Role of NK Cells, Interferons, and TNF
de réir: Mohanraj Manangeeswaran, et al.
Foilsithe / Cruthaithe: (2020-02-01)

Aberrant methylation of gene associated CpG sites occurs in borderline personality disorder.
de réir: Stefanie Teschler, et al.
Foilsithe / Cruthaithe: (2013-01-01)

Route of administration of the TLR9 agonist CpG critically determines the efficacy of cancer immunotherapy in mice.
de réir: Stefan Nierkens, et al.
Foilsithe / Cruthaithe: (2009-12-01)

The effects of O6-methyl guanine DNA-methyl transferase promotor methylation and CpG1, CpG2, CpG3 and CpG4 methylation on treatment response and their prognostic significance in patients with glioblastoma
de réir: Yildiz OG, et al.
Foilsithe / Cruthaithe: (2020-08-01)

Biophysical Attributes of CpG Presentation Control TLR9 Signaling to Differentially Polarize Systemic Immune Responses
de réir: Jardin A. Leleux, et al.
Foilsithe / Cruthaithe: (2017-01-01)

Cooperative activation of human TLR9 and consequences for the clinical development of antisense and CpG oligodeoxynucleotides
de réir: Gunther Hartmann
Foilsithe / Cruthaithe: (2023-12-01)

Development of CpG-oligodeoxynucleotides for effective activation of rabbit TLR9 mediated immune responses.
de réir: Tsung-Hsien Chuang, et al.
Foilsithe / Cruthaithe: (2014-01-01)

Immunotherapy of Malignant Glioma by Noninvasive Administration of TLR9 Agonist CpG Nano‐Immunoadjuvant
de réir: Jingjing Wei, et al.
Foilsithe / Cruthaithe: (2022-05-01)

In vivo control of CpG and non-CpG DNA methylation by DNA methyltransferases.
de réir: Julia Arand, et al.
Foilsithe / Cruthaithe: (2012-06-01)

pDC Activation by TLR7/8 Ligand CL097 Compared to TLR7 Ligand IMQ or TLR9 Ligand CpG
de réir: Jing Wu, et al.
Foilsithe / Cruthaithe: (2019-01-01)

Prediction of CpG-island function: CpG clustering vs. sliding-window methods
de réir: Luque-Escamilla Pedro L, et al.
Foilsithe / Cruthaithe: (2010-05-01)

The Effect of TLR9 Agonist CpG Oligodeoxynucleotides on the Intestinal Immune Response of Cobia (Rachycentron canadum)
de réir: Omkar Byadgi, et al.
Foilsithe / Cruthaithe: (2014-01-01)

PIKfyve regulates the endosomal localization of CpG oligodeoxynucleotides to elicit TLR9-dependent cellular responses.
de réir: Kaoru Hazeki, et al.
Foilsithe / Cruthaithe: (2013-01-01)

Reliable Detection of DNA CpG Methylation Profiles by the Isoschizomers MspI/HpaII Using Oligonucleotide Stimulators
de réir: Dagmar Kupper, et al.
Foilsithe / Cruthaithe: (1997-11-01)

Antibody Response Following the Intranasal Administration of SARS-CoV-2 Spike Protein-CpG Oligonucleotide Vaccine
de réir: Kentaro Muranishi, et al.
Foilsithe / Cruthaithe: (2023-12-01)

The In Ovo Delivery of CpG Oligonucleotides Protects against Infectious Bronchitis with the Recruitment of Immune Cells into the Respiratory Tract of Chickens
de réir: Upasama De Silva Senapathi, et al.
Foilsithe / Cruthaithe: (2018-11-01)

Alteration of T cell cytokine production in PLPp-139-151-induced EAE in SJL mice by an immunostimulatory CpG Oligonucleotide
de réir: Hemmer Bernhard, et al.
Foilsithe / Cruthaithe: (2011-05-01)

Conformation effects of CpG methylation on single-stranded DNA oligonucleotides: analysis of the opioid peptide dynorphin-coding sequences.
de réir: Malik Mumtaz Taqi, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Low biological fluctuation of mitochondrial CpG and non-CpG methylation at the single-molecule level
de réir: Chloe Goldsmith, et al.
Foilsithe / Cruthaithe: (2021-04-01)

Correlating CpG islands, motifs, and sequence variants in human chromosome 21
de réir: Cercone Nick, et al.
Foilsithe / Cruthaithe: (2011-07-01)

Nanoparticle System Based on Amino-Dextran as a Drug Delivery Vehicle: Immune-Stimulatory CpG-Oligonucleotide Loading and Delivery
de réir: Hien V. Nguyen, et al.
Foilsithe / Cruthaithe: (2020-11-01)

Adjuvant Activity of CpG-Oligonucleotide Administered Transcutaneously in Combination with Vaccination Using a Self-Dissolving Microneedle Patch in Mice
de réir: Sachiko Hirobe, et al.
Foilsithe / Cruthaithe: (2021-12-01)